IRIS
GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.759
NA - Nord America 2.598
EU - Europa 1.453
SA - Sud America 723
AF - Africa 67
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 4
Totale 15.671
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 7.800
US - Stati Uniti d'America 2.493
CN - Cina 1.307
HK - Hong Kong 959
BR - Brasile 549
IT - Italia 410
VN - Vietnam 378
GB - Regno Unito 331
DE - Germania 190
NL - Olanda 132
IN - India 88
EE - Estonia 73
AR - Argentina 69
AU - Australia 67
CA - Canada 65
ID - Indonesia 64
CZ - Repubblica Ceca 52
FI - Finlandia 40
EC - Ecuador 38
ZA - Sudafrica 34
FR - Francia 31
UA - Ucraina 31
MX - Messico 29
JP - Giappone 27
BD - Bangladesh 25
ES - Italia 22
PL - Polonia 22
RU - Federazione Russa 22
IR - Iran 19
TR - Turchia 19
CL - Cile 17
CO - Colombia 15
PY - Paraguay 15
BE - Belgio 14
SE - Svezia 14
MA - Marocco 10
LT - Lituania 9
PH - Filippine 8
AT - Austria 7
CH - Svizzera 7
MY - Malesia 7
PE - Perù 7
PK - Pakistan 7
RO - Romania 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
TH - Thailandia 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
GR - Grecia 4
IE - Irlanda 4
IL - Israele 4
IQ - Iraq 4
NP - Nepal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
EG - Egitto 3
KZ - Kazakistan 3
MK - Macedonia 3
NO - Norvegia 3
PT - Portogallo 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KR - Corea 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
RS - Serbia 2
UZ - Uzbekistan 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
RE - Reunion 1
SC - Seychelles 1
Totale 15.667
Salva come PNG Salva come JPEG
Città #
Hong Kong 948
Singapore 857
Ashburn 824
Hefei 613
Dallas 396
Boardman 368
London 271
Shanghai 204
Beijing 189
Ho Chi Minh City 137
Rome 114
Amsterdam 102
Council Bluffs 96
Hanoi 87
Munich 74
Tallinn 68
Los Angeles 67
São Paulo 50
San Francisco 46
Washington 43
Seattle 41
Brno 39
Milan 37
Santa Clara 36
Pune 30
West Jordan 26
Tokyo 24
Montreal 22
Perth 22
Brooklyn 21
Helsinki 21
Rio de Janeiro 21
New York 20
Melbourne 19
Toronto 19
Turku 18
Warsaw 18
Frankfurt am Main 17
Mexico City 17
Boston 15
Chennai 15
Chicago 15
Johannesburg 14
Brasília 13
Da Nang 13
Jinan 13
Thái Bình 13
Haiphong 12
Quito 12
Bengaluru 11
Hanover 11
Jakarta 11
Santiago 11
Biên Hòa 10
Guayaquil 10
Olomouc 10
Reggio Emilia 10
Stockholm 10
Sydney 10
Buenos Aires 9
Bắc Ninh 9
Porto Alegre 9
Xi'an 9
Zhengzhou 9
Bari 8
Belo Horizonte 8
Canberra 8
Hải Dương 8
Oxford 8
Salvador 8
Brussels 7
Campinas 7
Dhaka 7
Hortolândia 7
Manchester 7
Qingdao 7
San Jose 7
Turin 7
Asunción 6
Bocholt 6
Bologna 6
Buffalo 6
Can Tho 6
Caxias do Sul 6
Delhi 6
Fortaleza 6
Madrid 6
Manaus 6
Mauá 6
Phoenix 6
Secaucus 6
Viamão 6
Zhoukou 6
Ankara 5
Atlanta 5
Bogotá 5
Denver 5
Duque de Caxias 5
Ha Long 5
Juiz de Fora 5
Totale 6.535
Salva come PNG Salva come JPEG
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 413
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 226
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 215
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 212
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 206
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 205
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 204
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 202
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 201
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 200
Simultaneous presence of Brugada and overgrowth syndromes 199
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 198
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 196
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 196
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 194
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 193
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 191
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 190
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 190
Current management and prognosis of patients with recurrent myocardial infarction 189
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 189
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 188
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 187
Age and heart transplantation: results from a heart failure management unit. 187
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 185
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 184
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 181
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 178
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 177
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 174
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 159
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 145
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 138
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 120
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 113
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 109
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 106
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 104
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 102
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 101
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 100
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 99
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 97
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 96
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 95
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 95
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 94
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 92
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 91
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 90
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 89
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 88
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 87
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 83
Invasive Assessment of Coronary Microvascular Function 80
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 79
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 77
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 76
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 75
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 71
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 70
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 70
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 65
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 62
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 61
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 61
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 51
Evaluation of postural disorders in patients pre and post heart transplant. 46
Eosinophilic Myocarditis: From Bench to Bedside 44
The current paradigm of cardiac troponin increase among athletes 44
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 42
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 42
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 42
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 42
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 40
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 40
Effects of Environmental Conditions on Athlete's Cardiovascular System 40
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 40
Malattie valvolari, febbre reumatica 39
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 39
Reappraisal of the Concept and Implications of Pulmonary Hypertension in Degenerative Mitral Regurgitation 39
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 38
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 38
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 38
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 37
Mechanical circulatory support with centrifugal pump as bridge to heart transplantation 37
Ruolo residuo della terapia medica e con device nei pazienti affetti da scompenso cardiaco cronico riferiti per trapianto 37
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 37
Unusual rapid evolution of type B aortic dissection in a Marfan patient following heart transplantation: successful endovascular treatment. 37
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 37
Significato prognostico dei livelli plasmatici di endotelina-1 in pazienti con ipertensione arteriosa polmonare primitiva 37
Factors influencing post-surgical survival in degenerative mitral regurgitation 37
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 36
QRS interval time-related changes and prognosis in heart failure. 36
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 36
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 36
 RELAZIONE TRA PROFILO NEUROORMONALE E SOPRAVVIVENZA IN PAZIENTI CON IPERTENSIONE POLMONARE PRIMITIVA O PRECAPILLARE SECONDARIA 36
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 36
The Pilot European Survey of Atrial Fibrillation: How to look at heart failure through a keyhole 36
The Central Role of Left Atrium in Heart Failure 35
Totale 10.717
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022331 0 2 7 11 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/20263.577 822 376 849 1.295 235 0 0 0 0 0 0 0
Totale 15.846